GP
REGN icon

Girard Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Girard Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$11.4M Sell
10,818
-110
-1% -$107K 1.08% 21
2024
Q1 		$10.5M Buy
10,928
+86
+0.8% +$81.8K 0.99% 22
2023
Q4 		$9.52M Buy
10,842
+254
+2% +$209K 0.97% 28
2023
Q3 		$8.71M Buy
10,588
+142
+1% +$112K 0.98% 26
2023
Q2 		$7.51M Sell
10,446
-921
-8% -$710K 0.79% 30
2023
Q1 		$9.34M Buy
11,367
+2,828
+33% +$2.13M 1.03% 26
2022
Q4 		$6.16M Buy
8,539
+352
+4% +$260K 0.7% 33
2022
Q3 		$5.64M Buy
8,187
+2,024
+33% +$1.27M 0.75% 31
2022
Q2 		$3.64M Sell
6,163
-324
-5% -$211K 0.46% 59
2022
Q1 		$4.53M Sell
6,487
-189
-3% -$120K 0.5% 57
2021
Q4 		$4.22M Buy
6,676
+278
+4% +$171K 0.46% 69
2021
Q3 		$3.87M Buy
6,398
+66
+1% +$41K 0.49% 65
2021
Q2 		$3.54M Buy
6,332
+613
+11% +$311K 0.45% 70
2021
Q1 		$2.71M Buy
+5,719
New +$2.78M 0.39% 78
2018
Q4 		– Sell
-67
Closed -$27K – 680
2018
Q3 		$27K Buy
+67
New +$25.5K ﹤0.01% 553
2017
Q4 		– Sell
-467
Closed -$209K – 287
2017
Q3 		$209K Sell
467
-76
-14% -$36.2K 0.04% 241
2017
Q2 		$267K Buy
+543
New +$238K 0.06% 215

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Girard Partners's REGN Position: Q2 2024 in Review

Girard Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 1% in Q2 2024, selling an estimated $107K and leaving 10,818 shares worth $11.4M. The position accounts for 1.08% of the portfolio, ranked #21.

Girard Partners first reported a position in REGN in Q2 2017 and has held it in 17 quarters since. 1,331 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • Girard Partners held 10,818 shares of Regeneron Pharmaceuticals worth $11.4M as of Q2 2024.
  • Girard Partners sold 110 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $107K.
  • Regeneron Pharmaceuticals made up 1.08% of Girard Partners's portfolio in Q2 2024, its #21 holding.
  • Girard Partners first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 17 quarters since.
  • 1,331 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.